AGIOS PHARMACEUTICALS, INC.

By person

33 insiders · 430 transactions

6.6×

Brian Goff holds 6.6 times base salary in stock. $5.62M of shares against $846.86K in salary for 2025.

Salary from the company's own proxy. The shares are what Brian Goff last reported holding, valued at $30.48, the price Common stock was last bought or sold at on the open market here, on 4 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

CELGENE CORP /DE/ entity

10% owner

$69.53M (2)

—

+$69.53M

2,486,157

4.16%

$75.78M

+101.8%

Schenkein David P

Director

$249.98K (1)

$43.84M (63) scheduled

−$43.59M

397,014

0.6650%

$12.10M

+45.8%

Celgene European Investment Co LLC entity

10% owner

$30.92M (1)

—

+$30.92M

5,867,279

9.83%

$178.83M

+11.9%

NELSEN ROBERT

Director

—

$20.75M (15)

−$20.75M

109,230

0.1830%

$3.33M

−79.3%

Bowden Christopher

Chief Medical Officer

—

$12.62M (37) scheduled

−$12.62M

15,487

0.0259%

$472.04K

+1,086%

Biller Scott

Chief Scientific Officer

—

$12.34M (64) scheduled

−$12.34M

86,788

0.1454%

$2.65M

+16.4%

Goff Brian

Chief Executive Officer

—

$5.41M (19) scheduled

−$5.41M

184,508

0.3090%

$5.62M

—

Hoerter Steven L.

Chief Commercial Officer

—

$3.75M (10) scheduled

−$3.75M

10,941

0.0183%

$333.48K

—

Gheuens Sarah

Chief Medical Officer

—

$2.85M (24) scheduled

−$2.85M

54,645

0.0915%

$1.67M

+691.4%

Cantley Lewis Clayton Jr.

Director

—

$2.59M (66)

−$2.59M

158,990

0.2663%

$4.85M

−22.1%

Foster-Cheek Kaye I

Director

—

$2.24M (8) scheduled

−$2.24M

10,284

0.0172%

$313.46K

—

Burns James William

Chief Legal Officer

—

$2.10M (19) scheduled

−$2.10M

49,306

0.0826%

$1.50M

+406.2%

MARAGANORE JOHN

Director

—

$2.00M (3)

−$2.00M

30,028

0.0503%

$915.25K

−53.0%

Ballal Rahul D.

Director

—

$1.12M (5) scheduled

−$1.12M

15,230

0.0255%

$464.21K

—

Washburn Theodore James Jr.

Principal Accounting Officer

—

$1.06M (24)

−$1.06M

868

0.0015%

$26.46K

−71.1%

Jones Cecilia

Chief Financial Officer

—

$895.71K (15) scheduled

−$895.71K

54,998

0.0921%

$1.68M

+2,216%

Alenson Carman

Principal Accounting Officer

—

$773.19K (12)

−$773.19K

0.0000%

$0.00

−100.0%

Milanova Tsveta

Chief Commercial Officer

—

$741.86K (11) scheduled

−$741.86K

46,829

0.0784%

$1.43M

—

Miles Darrin

Chief Commercial Officer

—

$321.70K (3)

−$321.70K

7,209

0.0121%

$219.73K

+16.5%

Viswanadhan Krishnan

Chief Strategy and Operations

—

$184.97K (2) scheduled

−$184.97K

10,282

0.0172%

$313.40K

—

FOUSE JACQUALYN A

Director

$1.25M (1)

$1.14M (5) scheduled

+$112.27K

154,156

0.2582%

$4.70M

—

Scadden David

Director

$16.69K (1)

$98.22K (6) scheduled

−$81.54K

20,419

0.0342%

$622.37K

+5,404%

Hirsch Andrew

Chief Financial Officer

—

24,272

0.0407%

$739.81K

+808,967%

Biller Jonathan

Chief Financial Officer

—

22,953

0.0384%

$699.61K

+2,665%

Ho Maykin

Director

—

19,848

0.0332%

$604.97K

—

Car Bruce

Chief Scientific Officer

—

16,752

0.0281%

$510.60K

—

Smith Cynthia

Director

—

15,230

0.0255%

$464.21K

—

Owen Adams Catherine

Director

—

10,865

0.0182%

$331.17K

—

CAPELLO JEFFREY D

Director

—

10,865

0.0182%

$331.17K

—

Poddar Richa

Chief Commercial Officer

—

8,508

0.0143%

$259.32K

+1,112%

Clancy Paul J

Director

—

6,549

0.0110%

$199.61K

—

CLARK IAN T

Director

—

6,549

0.0110%

$199.61K

—

Backstrom Jay T.

Director

—

1,447

0.0024%

$44.10K

—

AGIOS PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out